Cargando…
Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
BACKGROUND: Polypharmacy is associated with poor outcomes in older adults. Targeted deprescribing of anticholinergic and sedative medications may improve health outcomes for frail older adults. Our pharmacist-led deprescribing intervention was a pragmatic 2-arm randomized controlled trial stratified...
Autores principales: | Jamieson, Hamish, Nishtala, Prasad S, Bergler, Hans Ulrich, Weaver, Susan K, Pickering, John W, Ailabouni, Nagham J, Abey-Nesbit, Rebecca, Gullery, Carolyn, Deely, Joanne, Gee, Susan B, Hilmer, Sarah N, Mangin, Dee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460556/ https://www.ncbi.nlm.nih.gov/pubmed/36692224 http://dx.doi.org/10.1093/gerona/glac249 |
Ejemplares similares
-
Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021) -
Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
por: Ailabouni, Nagham, et al.
Publicado: (2017) -
Challenges and Enablers of Deprescribing: A General Practitioner Perspective
por: Ailabouni, Nagham J., et al.
Publicado: (2016) -
Consumer Attitudes Towards Deprescribing: A Systematic Review and Meta-Analysis
por: Weir, Kristie Rebecca, et al.
Publicado: (2021) -
Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing
por: Gemikonakli, Gizem, et al.
Publicado: (2022)